KYORIN Holdings, Inc. (4569.T)

JPY 1440.0

(-0.89%)

Total Debt Summary of KYORIN Holdings, Inc.

  • KYORIN Holdings, Inc.'s latest annual total debt in 2023 was 20.94 Billion JPY , down -1.56% from previous year.
  • KYORIN Holdings, Inc.'s latest quarterly total debt in 2024 Q1 was 20.68 Billion JPY , down -1.25% from previous quarter.
  • KYORIN Holdings, Inc. reported annual total debt of 21.27 Billion JPY in 2022, down -1.6% from previous year.
  • KYORIN Holdings, Inc. reported annual total debt of 21.62 Billion JPY in 2021, down -1.18% from previous year.
  • KYORIN Holdings, Inc. reported quarterly total debt of 20.83 Billion JPY for 2023 Q2, down -0.24% from previous quarter.
  • KYORIN Holdings, Inc. reported quarterly total debt of 20.78 Billion JPY for 2023 Q3, down -0.24% from previous quarter.

Annual Total Debt Chart of KYORIN Holdings, Inc. (2023 - 2004)

Historical Annual Total Debt of KYORIN Holdings, Inc. (2023 - 2004)

Year Total Debt Total Debt Growth
2023 20.94 Billion JPY -1.56%
2022 21.27 Billion JPY -1.6%
2021 21.62 Billion JPY -1.18%
2020 21.88 Billion JPY -7.25%
2019 23.59 Billion JPY -1.79%
2018 24.02 Billion JPY 346.59%
2017 5.37 Billion JPY -2.68%
2016 5.52 Billion JPY -14.22%
2015 6.44 Billion JPY 62.74%
2014 3.95 Billion JPY 74.64%
2013 2.26 Billion JPY 11.18%
2012 2.03 Billion JPY -42.71%
2011 3.55 Billion JPY -52.53%
2010 7.49 Billion JPY 114.47%
2009 3.49 Billion JPY -34.56%
2008 5.34 Billion JPY 100.9%
2007 2.65 Billion JPY 78.46%
2006 1.49 Billion JPY -21.62%
2005 1.9 Billion JPY 0.0%
2004 - JPY 0.0%

Peer Total Debt Comparison of KYORIN Holdings, Inc.

Name Total Debt Total Debt Difference
Pharma Foods International Co., Ltd. 16.89 Billion JPY -24.007%
Takeda Pharmaceutical Company Limited 4843.75 Billion JPY 99.568%
Sumitomo Pharma Co., Ltd. 418.88 Billion JPY 95.0%
Shionogi & Co., Ltd. 11.62 Billion JPY -80.258%
Wakamoto Pharmaceutical Co.,Ltd. 100.52 Million JPY -20735.779%
Nippon Shinyaku Co., Ltd. 2.87 Billion JPY -629.318%
Kaken Pharmaceutical Co., Ltd. 3.85 Billion JPY -444.052%
Eisai Co., Ltd. 206.74 Billion JPY 89.869%
Morishita Jintan Co., Ltd. 425 Million JPY -4828.471%
Hisamitsu Pharmaceutical Co., Inc. 2.1 Billion JPY -897.429%
Mochida Pharmaceutical Co., Ltd. 369 Million JPY -5576.423%
Fuso Pharmaceutical Industries,Ltd. 12.72 Billion JPY -64.644%
Nippon Chemiphar Co., Ltd. 16.98 Billion JPY -23.35%
Tsumura & Co. 79.69 Billion JPY 73.716%
Kissei Pharmaceutical Co., Ltd. 1.72 Billion JPY -1112.855%
Torii Pharmaceutical Co., Ltd. 244 Million JPY -8484.426%
Towa Pharmaceutical Co., Ltd. 202.35 Billion JPY 89.649%
Fuji Pharma Co., Ltd. 28.94 Billion JPY 27.643%
Zeria Pharmaceutical Co., Ltd. 47.58 Billion JPY 55.983%
Taiko Pharmaceutical Co.,Ltd. 3.8 Billion JPY -449.908%
Daito Pharmaceutical Co.,Ltd. 8.71 Billion JPY -140.234%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 60 Million JPY -34810.0%
Modalis Therapeutics Corporation 412.5 Million JPY -4977.818%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.48 Billion JPY -120.833%
Sawai Group Holdings Co., Ltd. 82.89 Billion JPY 74.73%
Cyfuse Biomedical K.K. 913 Million JPY -2194.195%
Toho Holdings Co., Ltd. 30.24 Billion JPY 30.743%
Koa Shoji Holdings Co.,Ltd. 2.82 Billion JPY -641.376%